Iterum Therapeutics Announces Expiration and Results of Rights Offering

Stock Information for Iterum Therapeutics plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Iterum Therapeutics plc

Iterum Therapeutics Provides Business Update
Iterum Therapeutics Provides Business Update
Iterum Therapeutics Reports Third Quarter 2025 Financial Results
Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
Iterum Therapeutics to Present Data at IDWeek 2025
Iterum Therapeutics Provides Business Update
Iterum Therapeutics launches ORLYNVAH(TM), the first and only oral penem antibiotic in the U.S.
Iterum Therapeutics Reports Second Quarter 2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.